FARES Wassim 4
4 · Bellerophon Therapeutics, Inc. · Filed Sep 14, 2020
Insider Transaction Report
Form 4
FARES Wassim
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-10$10.12/sh+30,000$303,600→ 30,000 totalExercise: $10.12Exp: 2030-09-10→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the underlying shares on August 11, 2021 and the remaining options vest quarterly over a period of 3 years thereafter.